Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

Valeo Financial Advisors LLC decreased its holdings in Sanofi (NASDAQ:SNY – Free Report) by 62.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Sanofi India Ltd share price previously? Sanofi India Ltd share price was up by 3.49% from the previous closing ...

French healthcare company Sanofi announced on Friday a share buyback plan worth up to 2 billion euros ($2.1 billion), which ...

Sanofi announced the acquisition of 2.3% of its shares from L'Oréal. This transaction is part of share buyback program announced on ...

Paris: Sanofi has announced the acquisition of 2.3% of its shares from long-standing shareholder L’Oréal. This transaction is ...

Sanofi Consumer Healthcare India Ltd share price was down by 0.00% from the previous closing price of ₹4,706.90. Who are peers of Sanofi Consumer Healthcare India Ltd? The peers of Sanofi ...

especially if a substantial share buyback is announced. Parry also highlights Sanofi’s attractive valuation, citing a low price-to-earnings ratio relative to its growth outlook. Furthermore ...

Sanofi and Johnson & Johnson ended development of an experimental vaccine after it failed to adequately protect against an ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.